1. Home
  2. FSV vs APLS Comparison

FSV vs APLS Comparison

Compare FSV & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FirstService Corporation

FSV

FirstService Corporation

HOLD

Current Price

$141.43

Market Cap

6.4B

Sector

Finance

ML Signal

HOLD

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$40.64

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSV
APLS
Founded
1988
2009
Country
Canada
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.2B
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
FSV
APLS
Price
$141.43
$40.64
Analyst Decision
Strong Buy
Hold
Analyst Count
3
21
Target Price
$210.67
$32.71
AVG Volume (30 Days)
149.5K
7.2M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
112.50
EPS
N/A
0.20
Revenue
N/A
$1,003,782,000.00
Revenue This Year
$7.45
N/A
Revenue Next Year
$6.77
$18.21
P/E Ratio
$49.49
$202.05
Revenue Growth
N/A
28.46
52 Week Low
$133.42
$16.10
52 Week High
$205.99
$40.48

Technical Indicators

Market Signals
Indicator
FSV
APLS
Relative Strength Index (RSI) 47.21 87.73
Support Level $133.42 $19.38
Resistance Level $158.68 N/A
Average True Range (ATR) 3.88 0.52
MACD 0.80 2.91
Stochastic Oscillator 70.57 99.77

Price Performance

Historical Comparison
FSV
APLS

About FSV FirstService Corporation

FirstService Corp is engaged in outsourcing property services. The company operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertaPro Painters, Floor Coverings International, and Pillar to Post Home Inspectors. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).

Share on Social Networks: